| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2011 | Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers. | Lo, YL; Hsiao, CF; Jou, YS; Chang, GC; Tsai, YH; Su, WC; Chen, KY; Chen, YM; Huang, MS; Hsieh, WS; Chen, CJ; Hsiung, CA | LUNG CANCER 72(3), 280-286 | | | |
| 2012 | Pre-treatment EGFR T790M Mutation Predicts Shorter EGFR-TKI Response Duration in Non-small-cell Lung Cancer Patients | Su, KY; Chen, HY; Li, KC; Kuo, ML; Yang, James CH; Chan, WK; Ho, BC; Chang, GC; Shih, JY; Yu, SL; Yang, PC | JOURNAL OF CLINICAL ONCOLOGY doi: 10.1200/JCO.2011.38.3224 | | | |
| 2020 | Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model | Chien, LH; Chen, CH; Chen, TY; Chang, GC; Tsai, YH; Hsiao, CF; Chen, KY; Su, WC; Wang, WC; Huang, MS; Chen, YM; Chen, CY; Liang, SK; Chen, CY; Wang, CL; Lee, MH; Chung, RH; Tsai, FY; Hu, JW; Katki, HA; Chatterjee, N; Chanock, SJ; Rothman, N; Lan, Q; Yang, PC; Chen, CJ ; Chang, IS; Hsiung, CA | Cancer Epidemiology, Biomarkers & Prevention 29(2), 452-459 | | | |
| 2016 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients | Huang, YH; Hsu, KH; Tseng, JS; Chen, KC; Su, KY; Chen, HY ; Chang, CS; Chen, JJ; Yu, SL; Chen, HW; Yang, TY; Chang, GC | Journal of thoracic disease 8(1), 86-92 | | | |
| 2014 | Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaive patients with EGFR-mutant lung adenocarcinoma. | Tseng, JS; Yang, TY; Chen, KC; Hsu, KH; Yu, CJ; Liao, WY; Tsai, CR; Tsai, MH; Yu, SL; Su, KY; Chen, JJ; Chen, HY; Chang, GC | OncoTargets and therapy 7, 799-805 | | | |
| 2021 | Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers | Liang, SK; Chien, LH; Chang, GC; Tsai, YH; Su, WC; Chen, YM; Huang, MS; Lin, HC; Fang, WT; Hung, HH; Jiang, SS; Chen, CY; Chen, KY; Chang, IS; Hsiung, CA; Chen, CJ ; Yang, PC; GELAC Study Group | Frontiers in oncology 11, 753788 | | | |
| 2015 | R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability | Chen, HY; Yu, SL; Ho, BC; Su, KY; Hsu, YC; Chang, CS; Li, YC; Yang, SY; Hsu, PY; Ho, H; Chang, YH; Chen, CY; Yang, HI; Hsu, CP; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Hsia, JY; Chuang, CY; Yuan, S; Lee, MH; Liu, CH; Wu, GI; Hsiung, CA; Chen, YM; Wang, CL; Huang, MS; Yu, CJ; Chen, KY; Tsai, YH; Su, WC; Chen, HW; Chen, JJ; Chen, CJ; Chang, GC; Yang, PC; Li, KC | JOURNAL OF CLINICAL ONCOLOGY 33(20), 2303-2310 | | | |
| 2013 | Risk factors for primary lung cancer among never smokers by gender in a matched case-control study | Lo, YL; Hsiao, CF; Chang, GC; Tsai, YH; Chen, YM; Huang, MS; Su, WC; Chen, YM; Hsin, CW; Chang, CH; Yang, PC; Chen, CJ; Hsiung, CA | Cancer Cause Control 24(3), 567-76 | | | |
| 2014 | Shisa3 is associated with prolonged survival through promoting beta-catenin degradation in lung cancer. | Chen, CC; Chen, HY; Su, KY; Hong, QS; Yan, BS; Chen, CH; Pan, SH; Chang, YL; Wang, CJ; Hung, PF; Yuan, S; Chang, GC; Chen, JJ; Yang, PC; Yang, YC; Yu, SL | American journal of respiratory and critical care medicine 190(4), 433-44 | | | |
| 2016 | SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma | Hsiao, YJ; Su, KY; Hsu, YC; Chang, GC; Chen, JS; Chen, HY ; Hong, QS; Hsu, SC; Kang, PH; Hsu, CY; Ho, BC; Yang, TH; Wang, CY; Jou, YS; Yang, PC; Yu, SL | Oncotarget 7, 44417-44429 | | | |
| 2010 | The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia | Hsiung, CA; Lan, Q; Hong, YC; Chen, CJ; Hosgood, HD III; Chang, IS; Chatterjee, N; Brennan, P; Wu, C; Zheng, W; Chang, GC; Wu, T; Park, JY; Hsiao, CF; Kim, YH; Shen, H; Seow, A; Yeager, M; Tsai, YH; Kim, YT; Chow, WH; Guo, H; Wang, WC; Sung, SW; Hu, Z; Chen, KY; Kim, JH; Chen, Y; Huang, L; Lee, KM; Lo, YL; Gao, YT; Kim, JH; Liu, L; Huang, MS; Jung, TH; Jin, G; Caporaso, N; Yu, D; Kim, CH; Su, WC; Shu, XO; Xu, P; Kim, IS; Chen, YM; Ma, H; Shen, M; Cha, SI; Tan, W; Chang, CH; Sung, JS; Zhang, M; Yang, TY; Park, KH; Yuenger, J; Wang, CL; Ryu, JS; Xiang, Y; Deng, Q; Hutchinson, A; Kim, JS; Cai, Q; Landi, MT; Yu, CJ; Park, JY; Tucker, M; Hung, JY; Lin, CC; Perng, RP; Boffetta, P; Chen, CY; Chen, KC; Yang, SY; Hu, CY; Chang, CK; Fraumeni, JF; Chanock, S; Yang, PC; Rothman, N; Lin, D | PLoS Genetics 6(8). pii: e1001051. | | | |
| 2020 | The M1/M2 Spectrum and Plasticity of Malignant Pleural Effusion-Macrophage in Advanced Lung Cancer | Wu, MF; Lin, CA; Yuan, TH; Yeh, HY; Su, SF; Guo, CL ; Chang, GC; Li, KC ; Ho, CC; Chen, HW | Cancer Immunology, Immunotherapy 70, 1435-1450 | | | |
